Results 191 to 200 of about 28,421 (276)

Supplementary Table S1 from A Pilot Study of Neoadjuvant Nivolumab, Ipilimumab, and Intralesional Oncolytic Virotherapy for HER2-negative Breast Cancer

, 2023
Vina P. Nguyen, Katie M. Campbell, Theodore S. Nowicki, Nila Elumalai, Egmidio Medina, Ignacio Baselga-Carretero, Maggie L. DiNome, Helena R. Chang, Denise K. Oseguera, Antoni Ribas, John A. Glaspy   +10 more
openalex   +1 more source

Oncolytic virotherapy and tumor microenvironment modulation. [PDF]

Clin Exp Med
Rivera-Orellana S, Bautista J, Palacios-Zavala D, Ojeda-Mosquera S, Altamirano-Colina A, Alcocer-Veintimilla M, Parrales-Rosales G, Izquierdo-Condoy JS, Vásconez-González J, Ortiz-Prado E, Muslin C, López-Cortés A.   +11 more
europepmc   +1 more source

Oncolytic virotherapy-mediated anti-tumor response: a single-cell perspective.

Cancer Cell, 2021
E. Ramelyte, A. Tastanova, Zsolt Balázs, D. Ignatova, P. Turko, U. Menzel, Emmanuella Guenova, C. Beisel, M. Krauthammer, M. Levesque, R. Dummer   +10 more
semanticscholar   +1 more source

Oncolytic Virotherapy in Colorectal Cancer: Mechanistic Insights, Enhancer Strategies, and Translational Combinations. [PDF]

Cells
Salameh H, Naseem N, Chattha MA, Ramesh J, Ramy H, Cizkova D, Kubatka P, Büsselberg D.   +7 more
europepmc   +1 more source

Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy

Cell, 2017
A. Ribas, R. Dummer, I. Puzanov, A. VanderWalde, R. Andtbacka, O. Michielin, A. Olszanski, J. Malvehy, J. Cebon, Eugenio Fernandez, J. Kirkwood, T. Gajewski, Lisa Chen, K. Gorski, A. Anderson, Scott J. Diede, Michael E. Lassman, J. Gansert, F. Hodi, G. Long   +19 more
semanticscholar   +1 more source

Immunohistochemistry for Tumor-Infiltrating Immune Cells After Oncolytic Virotherapy

, 2019
Dipongkor Saha, Samuel D. Rabkin
openalex   +2 more sources

Oncolytic Virotherapy in Solid Tumors: A Current Review. [PDF]

BioDrugs
Chen C, Cillis J, Deshpande S, Park AK, Valencia H, Kim SI, Lu J, Vashi Y, Yang A, Zhang Z, Woo Y, Fong Y, Chaurasiya S.   +12 more
europepmc   +1 more source

Infectious bursal disease virus (IBDV) as a novel oncolytic virotherapy in glioblastoma. [PDF]

J Immunother Cancer
Tur-Planells V, Bykov Y, Dawodu G, García-Romero N, Izpura-Luis S, Pérez-Rodríguez L, Rius-Rocabert S, Palacín-Aliana I, Arranz-Herrero J, Márquez-Leiva I, Monago-Sanchez A, Del Rio ML, Rodriguez-Barbosa JI, Cano-Ochando J, García-Sastre A, Lozano-Ojalvo D, Nistal-Villan E, Ayuso-Sacido A, Cuadrado-Castano S.   +18 more
europepmc   +1 more source

The role of viral dynamics and infectivity in models of oncolytic virotherapy for tumours with different motility [PDF]

David Morselli, Federico Frascoli, Marcello Delitala   +2 more
openalex   +1 more source

Oncolytic virotherapy in glioblastoma patients induces a tumor macrophage phenotypic shift leading to an altered glioblastoma microenvironment [PDF]

, 2018
Wouter van den Bossche, Anne Kleijn, Charlotte E. Teunissen, Jane S.A. Voerman, Cristina Teodósio, David P. Noske, Jacques J. M. van Dongen, Clemens M.F. Dirven, Martine L.M. Lamfers   +8 more
openalex   +1 more source